Third, tumor subsets enriched for immune markers, including cytotoxic immune genes (e.g., Prf1, Gzmb, Gzmg) and mast cell protease genes (e.g., Mcpt1, Cma1, Tpsb2). This evidence concerns the gene CMA1 and neoplasm.